( June 23, 2025, 12:02 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on June 23 invited the government to express its views on a petition for a writ of certiorari filed by a bioequivalent drug manufacturer that contends that the Federal Circuit U.S. Court of Appeals was wrong to reverse a Delaware federal judge’s finding of no induced infringement in a dispute over patents related to a prescription cardiovascular medication....